Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China (2021 edition)-Reference-Cited by-同舟云学术

Clinical practice guideline on liver transplantation for hepatocellular carcinoma in China (2021 edition)

Published:2022-12-20 Issue:24 Volume:135 Page:2911-2913
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Chen Jun¹,Shen Tian²,Li Jianhui³,Ling Sunbin¹,Yang Zhe³,Wang Guoying⁴,Sun Liying⁵,Yang Zhaoxu⁶,Zhuang Li³,Gao Jie⁷,Guo Wenyuan⁸,Li Jie¹,Xu Shengjun¹,Wei Qiang¹,Zheng Shusen²³,Xu Xiao¹

Affiliation:

1. Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hangzhou First Hospital, Zhejiang University School of Medicine, Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Hangzhou, Zhejiang 310006, China

2. Department of Liver Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China

3. Department of Hepatobiliary and Pancreatic Surgery, Shulan (Hangzhou) Hospital, Hangzhou, Zhejiang 310004, China

4. Department of Hepatobiliary Surgery, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510120, China

5. Liver Transplantation Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China

6. Department of Hepatobiliary Surgery, Xijing Hospital, Air Force Medical University, Xi’an, Shaanxi 710032, China

7. Department of Hepatobiliary Surgery, People's Hospital, Peking University, Beijing 100044, China

8. Department of Liver Surgery and Organ Transplantation, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference4 articles.

1. Cancer incidence and mortality in China, 2014;Chen;Chin J Cancer Res,2018

2. Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: a multicenter study from China;Zhan;Hepatobiliary Pancreat Dis Int,2020

3. Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis;Wong;J Hepatol,2019

4. Efficacy and safety of everolimus with reduced tacrolimus in liver transplant recipients: 24-month results from the pooled analysis of 2 randomized controlled trials;Lee;Transplantation,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gp78 deficiency in hepatocytes alleviates hepatic ischemia-reperfusion injury via suppressing ACSL4-mediated ferroptosis;Cell Death & Disease;2023-12-08

2. Bioequivalue of two mycophenolate sodium enteric-coated tablets and the drug monitoring based on limited sampling strategy: A single-center, randomized, open-label, three-period, reference-replicated, crossover study;Transplant Immunology;2023-12

3. Incorporation of protein induced by vitamin K absence or antagonist-II into transplant criteria expands beneficiaries of liver transplantation for hepatocellular carcinoma: a multicenter retrospective cohort study in China;International Journal of Surgery;2023-11-20

4. TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma;Journal for ImmunoTherapy of Cancer;2023-11

5. Editorial: Liver transplantation for liver cancer in the era of transplant oncology: accurate diagnosis and treatment;Frontiers in Immunology;2023-09-11